AI Becoming as Vital as Water and Power AEM Holdings CEO Points to Surging Chip Testing Demand Plus500 Reports 11 Revenue Growth Reaffirms FullYear Guidance Manchesters Defining Spirit How Andy Burnhams Economic Philosophy Could Reshape UK Investment Landscape Novartis Raises FullYear Guidance Signaling Strong Growth Prospects Michael Saylor of Strategy Says Tokenization Could Enable Investors to Shop for Yield Accenture Faces AI Disruption Concerns as Market Debates Overreaction Shinhan Financial Group Q4 2025 Earnings EPS Miss of 35 on Higher Provisions SLM Q1 2026 Earnings EPS Surges Past Estimates by 356 Stock Slips First Business Financial Services FBIZ Q1 2026 Earnings Slight EPS Miss and Marginal Stock Decline SLB Q1 2026 Earnings Marginal EPS Miss Stock Edges Up Amid Mixed Market Signals WLY Q1 2026 Earnings EPS Surprises by 1167 as Publishing Firm Beats Estimates SIMPPLE Ltd SPPL Nears Key Support After 191 Decline Oracle ORCL Edges Higher as Buyers Defend Key Support Zone 1RT Acquisition Corp ONCH Holds Steady Near Resistance RangeBound Action Continues Oaktree Specialty Lending Corporation OCSL Edges Higher as Support Holds Steady Globa Terra Acquisition Rights GTERR Remain Steady at 011 as Trading Volume Stays Minimal Trucking Industry Faces Urgent Need for Faster Adaptation Amid Regulatory Shifts and AI Disruption Experts Caution BrightView Holdings Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Earnings Shortfall Haoxi Health Technology Limited HAO Plunges 16 Key Levels to Watch GEVO Q1 2026 Earnings Significant EPS Miss Amid Operational Transition SAM Q1 2026 Earnings EPS Misses Estimates Amidst Persistent Cost Headwinds SRBK Q3 2025 Earnings Modest Profitability Amid Quiet Market Reaction FIS Q1 2026 Earnings EPS Beats Estimates by 464 as Profitability Takes Center Stage MTH Q1 2026 Earnings Earnings Miss Estimates Despite Modest Stock Uptick CVSA Q1 2026 Earnings Strong EPS Surprise Drives Optimistic Start to Fiscal Year Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn